Detalhe da pesquisa
1.
Osteonecrosis of the jaw among patients with cancer treated with denosumab or zoledronic acid: Results of a regulator-mandated cohort postauthorization safety study in Denmark, Norway, and Sweden.
Cancer
; 127(21): 4050-4058, 2021 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34310704
2.
Code of practice needed for samples donated by trial participants - Sponsor's reply.
Lancet Oncol
; 23(3): e91, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35240092
3.
Denosumab compared with zoledronic acid on PFS in multiple myeloma: exploratory results of an international phase 3 study.
Blood Adv
; 5(3): 725-736, 2021 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33560384
4.
Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis.
Adv Ther
; 37(7): 3404-3416, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32524500